Fas/FasL诱导的细胞凋亡机制及其在肿瘤免疫方面研究的进展

被引：4

作者：

李民 ^{[1
]}

陈阵 ^{[2
]}

任华 ^{[1
]}

赵秋萍 ^{[1
]}

机构：

[1] 解放军第医院检验科

[2] 大连医科大学附属第一医院检验科

来源：

实用医学杂志 | 2006年 / 06期

关键词：

Fas/FasL; 肿瘤免疫; 细胞凋亡;

D O I：

暂无

中图分类号：

R730.3 [肿瘤免疫学与血清学];

学科分类号：

100214 ;

摘要：

引用

页码：729 / 730

页数：2

共 10 条

[1]

CD95-CD95L:canthebrainlearnfromtheimmunesystem. BECHERB,BARKERPA,OWENST,etal. Trends in Neurosciences . 1998

[2]

Apoptosisbydeathfactor. NAGATAS. Cell . 1997

[3]

PrognosticsignificanceofsolubleFasintheserumofpatientswithbladdercancer. IZUTANIY,YOSHIOLAO,BANAVIDAB,etal. The Journal of Urology . 1998

[4]

Humanpanereaticcancercellsexpressnon-functionalFasreceptorsandconterattacklymphocytesbyexpressingFasligand:apotentialmechanismforimmuneescape. ELNEMRA,OHTAT,YACHIEA,etal. International Journal of Oncology . 2001

[5]

MelanomacellexpressionofFas(Apol/CD95)ligand:implicationsoftumorimmuneescape. HAHNEM,RIMOLDID,SCHROTERM,etal. Science . 1996

[6]

HumanlungcarcinomasexpressFasligand. IEHANSGA,BRUNNERT,FRIZELLESP,etal. Cancer Research . 1997

[7]

ExpressionofthefunctionalsolubleformofhumanFasLigandinactivatedlymphocytes. TANAKAM,SUDAT,TAKAHASHIT,etal. EMBO Journal . 1995

[8]

ACASP-8mutationrecognizedbycytolyticTlymphocytesonahumanheadandneckcarcinoma. MADRUZZATOS,BRASSEURF,ANDRYG,etal. The Journal of Experimental Medicine . 1997

[9]

InfluenceofinterferongammaonmodulationofFasexpressionbyhumancoloncarcinomacellsandtheirsubsequentsensitivitytoantigen-specificCD8+cytotoxiTlymphocyteattack. BERGMANN,LEITNERES,ABRAMSSI,etal. CancerImmunolImmunother . 2000

[10]

ExpressionofFas(Apo-1/CD95)intumor-infiltratingandperipheralbloodlymphocytesinpatientswithrenalcellcarcinoma. CARDIG,HEANEYJA,SCHNEDAR,etal. Cancer Research . 1998

← 1 →